Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia

Ángel L. Montejo; Celso Arango; Miquel Bernardo; Josep L. Carrasco; Benedicto Crespo‐Facorro; Juan Jesús Cruz; Javier del Pino; Miguel Alfonso García Escudero; Clemente García‐Rizo; Ana González‐Pinto; Ana I. Hernández; Manuel Martín Carrasco; Fermín Mayoral; Jacqueline Mayoral-van Son; M.T. Mories; Isabella Pachiarotti; Salvador Ros; Eduard Vieta

doi:10.1016/j.rpsmen.2016.06.001

Related publications

Article2008

Spanish Consensus on Physical Health of Patients With Bipolar Disorder

Julio Bobes, Jerónimo Sáiz Ruiz, José Manuel García Montes, José M. Mostaza, Fernando Rico‐Villademoros, Eduard Vieta

Article2025

Treatment-resistant depression and intranasal esketamine: Spanish consensus on theoretical aspects

Fernando Mora, Josep Antoni Ramos‐Quiroga, Enrique Baca‐García, José Manuel Crespo, Luís Gutiérrez-Rojas, Aránzazu Madrazo, Lucía Pérez-Costillas, Pilar A. Sáiz, Vicente Tordera, Eduard Vieta

Article2007

Balancing the Benefits and Risks of Drug Treatment

Seston Em, Darren M. Ashcroft, Christopher Em Griffiths

Article2025

Treatment-resistant depression and intranasal esketamine: Spanish clinical consensus on practical aspects

Josep Antoni Ramos‐Quiroga, Fernando Mora, Silvia Arostegui, Narcı́s Cardoner, Jon-Iñaki Etxeandia-Pradera, Rocío Gómez-Juanes, Marcos Gómez‐Revuelta, José Manuel García Montes, Eduard Vieta

Article2009

Spanish Consensus on Physical Health in Patients with Bipolar Disorder [P01-205]

J. Sáiz‐Ruiz, Julio Bobes, Eduard Vieta, José M. Mostaza